T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.47% |
| 2 | Healthcare | 18.68% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Evercore
EVR
$12B
| $839K | ﹤0.01% |
18,226
+3,180
| +21% | +$213K |
|
|
CVSA
1777
Covista Inc
CVSA
$4.46B
| $836K | ﹤0.01% |
31,209
+4,703
| +18% | +$150K |
|
1778
Strategy Inc
MSTR
$36.6B
| $836K | ﹤0.01% |
70,790
+510
| +0.7% | +$6.93K |
|
|
RPT
1779
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $835K | ﹤0.01% |
138,409
+2,502
| +2% | +$31.3K |
|
|
MIC
1780
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $835K | ﹤0.01% |
33,060
+7,163
| +28% | +$274K |
|
1781
Cohen & Steers
CNS
$4.38B
| $833K | ﹤0.01% |
18,333
+3,396
| +23% | +$215K |
|
1782
Hecla Mining
HL
$12.5B
| $829K | ﹤0.01% |
455,242
+67,942
| +18% | +$188K |
|
|
CIT
1783
DELISTED
CIT Group Inc.
CIT
| $826K | ﹤0.01% |
47,878
-15,375
| -24% | -$580K |
|
1784
Tootsie Roll Industries
TR
$3.06B
| $823K | ﹤0.01% |
27,318
+162
| +0.6% | +$4.57K |
|
|
PINC
1785
DELISTED
Premier
PINC
| $821K | ﹤0.01% |
25,085
+65
| +0.3% | +$2.12K |
|
1786
OneMain Financial
OMF
$7.54B
| $820K | ﹤0.01% |
42,872
+9,569
| +29% | +$357K |
|
1787
Plexus
PLXS
$7.15B
| $817K | ﹤0.01% |
14,966
+182
| +1% | +$12.3K |
|
1788
Bank OZK
OZK
$5.75B
| $805K | ﹤0.01% |
48,249
+3,353
| +7% | +$86.2K |
|
1789
Central Garden & Pet Co Class A
CENTA
$2.42B
| $801K | ﹤0.01% |
39,151
+48
| +0.1% | +$1.07K |
|
1790
Trustmark
TRMK
$2.82B
| $801K | ﹤0.01% |
34,363
+9,004
| +36% | +$268K |
|
1791
Independence Realty Trust
IRT
$4.01B
| $799K | ﹤0.01% |
89,343
+36,710
| +70% | +$496K |
|
1792
Myriad Genetics
MYGN
$299M
| $795K | ﹤0.01% |
55,542
+410
| +0.7% | +$8.66K |
|
1793
Cathay General Bancorp
CATY
$4.34B
| $794K | ﹤0.01% |
34,605
+410
| +1% | +$13.1K |
|
|
SASR
1794
DELISTED
Sandy Spring Bancorp Inc
SASR
| $794K | ﹤0.01% |
35,056
+4,008
| +13% | +$128K |
|
|
VGR
1795
DELISTED
Vector Group Ltd.
VGR
| $793K | ﹤0.01% |
118,712
+11,717
| +11% | +$103K |
|
|
REGI
1796
DELISTED
Renewable Energy Group, Inc.
REGI
| $791K | ﹤0.01% |
38,546
-55,964
| -59% | -$1.42M |
|
1797
Walker & Dunlop
WD
$1.48B
| $790K | ﹤0.01% |
19,614
+1,766
| +10% | +$111K |
|
1798
Medifast
MED
$130M
| $789K | ﹤0.01% |
12,626
-2,095
| -14% | -$191K |
|
1799
Kulicke & Soffa
KLIC
$5.07B
| $787K | ﹤0.01% |
37,700
+2,000
| +6% | +$49K |
|
|
UCB
1800
United Community Banks
UCB
$4.45B
| $783K | ﹤0.01% |
42,751
+7,410
| +21% | +$191K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.